Surgical treatment of chest wall tuberculosis_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

WU Banggui ,  JIANG Liangshuang , ZHONG Ming , GONG Sheng , JIA Shuang , LI Xiao , LIU Chao

Department of Thoracic Surgery, Chengdu Public Health Clinical Medical Center, Chengdu, 610066, P.R.China;

Corresponding author：

JIANG Liangshuang, Email: hdnhuqivn@163.com

Keywords：

Chest wall tuberculosis; surgery; recurrence

DOI：

10.7507/1007-4848.202001050

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the effect of surgical treatment on chest wall tuberculosis.Methods A total of 407 patients with chest wall tuberculosis who met the inclusion and exclusion criteria from April 2008 to December 2017 in Chengdu Public Health Clinical Medical Center were enrolled. They were divided into two groups according to the time of admission: a control group (203 patients admitted from April 2008 to December 2012) treated with traditional focus debridement, including 135 males and 68 females, with an average age of 40.65±4.68 years, and an observation group (204 patients admitted from 2013 to 2017) undergoing complete focus debridement, including 139 males and 65 females, with an average age of 40.73±4.72 years. The general clinical data, perioperative related indexes, incision healing, incidence of complications and recurrence between the two groups were compared.Results There was no significant difference in general clinical data, operation time, postoperative pain time, extubation time, hospital stay or recurrence rate between the two groups (P>0.05), but compared with the control group the grade A healing rate in the observation group was significantly higher and incidence of complications was significantly lower (P<0.05).Conclusion Thorough debridement can achieve a better effect in the treatment of chest wall tuberculosis, and help to reduce complications and promote wound healing. It is suitable for clinical application.

Citation： WU Banggui, JIANG Liangshuang, ZHONG Ming, GONG Sheng, JIA Shuang, LI Xiao, LIU Chao. Surgical treatment of chest wall tuberculosis. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2020, 27(10): 1207-1210. doi: 10.7507/1007-4848.202001050 Copy

1.	仲毅. 胸壁结核术后切口愈合不良的相关因素研究. 安徽医科大学, 2019.
2.	仲毅, 卢兴时, 陈康, 等. 胸壁结核诊断及治疗的研究现状. 中国胸心血管外科临床杂志, 2019, 26(9): 926-932.
3.	Subotic D, Yablonskiy P, Sulis G, <italic>et al</italic>. Surgery and pleuro-pulmonary tuberculosis: a scientific literature review. J Thorac Dis, 2016, 8(7): E474-E485.
4.	宋东梅. 超声造影在胸壁结核穿刺活检中的应用价值. 中国当代医药, 2017, 24(6): 68-70.
5.	蔡伟鹏. 超声引导经皮穿刺治疗在胸壁结核患者中的应用价值. 中国药物经济学, 2017, 12(2): 110-112.
6.	罗小英, 刘姝, 岳冀, 等. 108 例胸壁结核的超声影像表现分析. 实用医院临床杂志, 2016, 13(5): 198-200.
7.	姜友定, 连贵勇, 陈穗, 等. 363 例胸壁结核性脓肿的手术治疗总结. 岭南现代临床外科, 2015, 15(6): 652-655.
8.	刘兴元, 徐翼, 纪沛君, 等. 手术治疗复发性胸壁结核的效果评价. 西部医学, 2018, 30(11): 1607-1611.
9.	张卫东, 魏金星, 刘渊源, 等. 术前超短程化疗联合手术治疗胸壁结核的疗效观察. 中国胸心血管外科临床杂志, 2018, 25(10): 865-869.
10.	周雨, 梁雄斌, 游长胜, 等. 胸腺五肽联合常规抗结核治疗在胸壁结核术后患者中的应用效果观察. 白求恩医学杂志, 2017, 15(6): 746-748.
11.	何锋, 张霓, 付向宁. 带蒂大网膜在难治性胸壁结核外科治疗中的应用. 中国继续医学教育, 2018, 10(20): 75-77.
12.	Alexander GR, Biccard B. A retrospective review comparing treatment outcomes of adjuvant lung resection for drug-resistant tuberculosis in patients with and without human immunodeficiency virus co-infection. Eur J Cardiothorac Surg, 2016, 49(3): 823-828.
13.	韩亢. 胸壁结核合并胸膜炎的外科治疗体会. 吉林医药学院学报, 2016, 37(4): 280-281.
14.	Han YI, Zhao Q, Yu D, <italic>et al</italic>. Treatment of chest wall tuberculosis with transdermal ultrasound-mediated drug delivery. Exp Ther Med, 2015, 9(4): 1433-1437.
15.	Umanah TA, Ncayiyana JR, Nyasulu PS. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa. Trans R Soc Trop Med Hyg, 2015, 109(5): 340-348.
16.	单国际. 伴有肋骨破坏的胸壁结核减创手术治疗体会. 中国医师进修杂志, 2018, 41(6): 541-542.

1. 仲毅. 胸壁结核术后切口愈合不良的相关因素研究. 安徽医科大学, 2019.
2. 仲毅, 卢兴时, 陈康, 等. 胸壁结核诊断及治疗的研究现状. 中国胸心血管外科临床杂志, 2019, 26(9): 926-932.
3. Subotic D, Yablonskiy P, Sulis G, <italic>et al</italic>. Surgery and pleuro-pulmonary tuberculosis: a scientific literature review. J Thorac Dis, 2016, 8(7): E474-E485.
4. 宋东梅. 超声造影在胸壁结核穿刺活检中的应用价值. 中国当代医药, 2017, 24(6): 68-70.
5. 蔡伟鹏. 超声引导经皮穿刺治疗在胸壁结核患者中的应用价值. 中国药物经济学, 2017, 12(2): 110-112.
6. 罗小英, 刘姝, 岳冀, 等. 108 例胸壁结核的超声影像表现分析. 实用医院临床杂志, 2016, 13(5): 198-200.
7. 姜友定, 连贵勇, 陈穗, 等. 363 例胸壁结核性脓肿的手术治疗总结. 岭南现代临床外科, 2015, 15(6): 652-655.
8. 刘兴元, 徐翼, 纪沛君, 等. 手术治疗复发性胸壁结核的效果评价. 西部医学, 2018, 30(11): 1607-1611.
9. 张卫东, 魏金星, 刘渊源, 等. 术前超短程化疗联合手术治疗胸壁结核的疗效观察. 中国胸心血管外科临床杂志, 2018, 25(10): 865-869.
10. 周雨, 梁雄斌, 游长胜, 等. 胸腺五肽联合常规抗结核治疗在胸壁结核术后患者中的应用效果观察. 白求恩医学杂志, 2017, 15(6): 746-748.
11. 何锋, 张霓, 付向宁. 带蒂大网膜在难治性胸壁结核外科治疗中的应用. 中国继续医学教育, 2018, 10(20): 75-77.
12. Alexander GR, Biccard B. A retrospective review comparing treatment outcomes of adjuvant lung resection for drug-resistant tuberculosis in patients with and without human immunodeficiency virus co-infection. Eur J Cardiothorac Surg, 2016, 49(3): 823-828.
13. 韩亢. 胸壁结核合并胸膜炎的外科治疗体会. 吉林医药学院学报, 2016, 37(4): 280-281.
14. Han YI, Zhao Q, Yu D, <italic>et al</italic>. Treatment of chest wall tuberculosis with transdermal ultrasound-mediated drug delivery. Exp Ther Med, 2015, 9(4): 1433-1437.
15. Umanah TA, Ncayiyana JR, Nyasulu PS. Predictors of cure among HIV co-infected multidrug-resistant TB patients at Sizwe Tropical Disease Hospital Johannesburg, South Africa. Trans R Soc Trop Med Hyg, 2015, 109(5): 340-348.
16. 单国际. 伴有肋骨破坏的胸壁结核减创手术治疗体会. 中国医师进修杂志, 2018, 41(6): 541-542.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Surgical treatment of chest wall tuberculosis

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content